Se-Jin Lee was elected member to the National Academy of Sciences on 28 April 2012. Dr Lee is responsible for the discovery of myostatin, a critical regulator of skeletal muscle mass and function. He also determined the primary binding receptor for myostatin, and has characterized additional transforming growth factor-β family members acting in this pathway.
have naturally occurring disruptions of the myostatin locus [3] .
Dr Lee went on to extensively study myostatin, and in subsequent papers demonstrated the loss of white fat that occurs upon induction of hypermuscularity by myostatin inhibition [4] , and that administration of myostatin was sufficient to cause a phenotype reminiscent of cachexia [5] . He next showed that myostatin was regulated by a metalloprotease that activates it from a latent state [6] , and identified the activin receptor type IIb receptor as one of the key receptors for myostatin [7] . This last paper highlighted an ongoing trend of first-author manuscripts for Dr Lee, a testament to his continued commitment to working at the bench.
Finally, Dr Lee has shown that other molecules in the TGF-β pathway, notably the activins and follistatin, also regulate muscle mass [8, 9] . Dr Lee's contributions include the demonstration of potential therapeutic benefits for myostatin inhibition. The precise clinical setting in which myostatin blockade might be beneficial has not yet been finally determined in humans, but it is at least clear that human null mutations for myostatin have a similar phenotype of hypermuscularity [10] . One potential area for blockade of this family of factors is cancer cachexia, as was demonstrated with an activin receptor IIb trap [11] .
Dr Lee's election to the Academy represents great recognition both for him and for the skeletal muscle field as a whole. His career is a testament to continued close study of a mechanism, leading to the initiation of an entirely new field of basic and biomedical research.
